CAPTRUST Financial Advisors Portfolio holdings
AUM
$44.8B
1-Year Return
16.03%
This Quarter Return
-2.59%
1 Year Return
+16.03%
3 Year Return
+60.22%
5 Year Return
+112.11%
10 Year Return
+201.46%
AUM
$26.2B
AUM Growth
+$798M
(+3.1%)
Cap. Flow
+$1.56B
Cap. Flow
% of AUM
5.95%
Top 10 Holdings %
Top 10 Hldgs %
23.81%
Holding
2,723
New
199
Increased
1,365
Reduced
896
Closed
147
Top Buys
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$69.5M |
| 2 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$62.9M |
| 3 |
Microsoft
MSFT
|
+$50.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$48.8M |
| 5 |
Vanguard Growth ETF
VUG
|
+$47.4M |
Top Sells
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$67.1M |
| 2 |
Jefferies Financial Group
JEF
|
+$36.9M |
| 3 |
Broadcom
AVGO
|
+$35.8M |
| 4 |
Lamar Advertising Co
LAMR
|
+$30.5M |
| 5 |
Webster Financial
WBS
|
+$21.7M |
Sector Composition
| 1 | Technology | 12.63% |
| 2 | Healthcare | 6.84% |
| 3 | Financials | 6.61% |
| 4 | Consumer Discretionary | 4.7% |
| 5 | Industrials | 4.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Douglas Elliman
DOUG
$253M
| $34.8K | ﹤0.01% |
15,414
+3,218
| +26% | +$7.27K |
|
|
DHC
2502
Diversified Healthcare Trust
DHC
$1.04B
| $34.8K | ﹤0.01% |
+17,941
| New | +$34.8K |
|
2503
Shore Bancshares
SHBI
$568M
| $31.5K | ﹤0.01% |
+2,996
| New | +$31.5K |
|
2504
Adverum Biotechnologies
ADVM
$74.3M
| $30.8K | ﹤0.01% |
+2,050
| New | +$30.8K |
|
|
BHR
2505
Braemar Hotels & Resorts
BHR
$203M
| $30.1K | ﹤0.01% |
+10,869
| New | +$30.1K |
|
2506
Outlook Therapeutics
OTLK
$42M
| $30.1K | ﹤0.01% |
6,807
+5,779
| +562% | +$25.5K |
|
|
AMLI
2507
DELISTED
American Lithium Corp. Common Stock
AMLI
| $29.2K | ﹤0.01% |
20,429
-12,496
| -38% | -$17.9K |
|
2508
Dyadic International
DYAI
$32.9M
| $28.8K | ﹤0.01% |
15,000
| – | – |
|
2509
C4 Therapeutics
CCCC
$193M
| $27.6K | ﹤0.01% |
14,855
-1,875
| -11% | -$3.49K |
|
|
DHY
2510
Credit Suisse High Yield Bond Fund
DHY
$217M
| $27.3K | ﹤0.01% |
14,525
+251
| +2% | +$472 |
|
|
TVRD
2511
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
| $26.7K | ﹤0.01% |
442
-33
| -7% | -$2K |
|
2512
Atara Biotherapeutics
ATRA
$85.5M
| $26.7K | ﹤0.01% |
+721
| New | +$26.7K |
|
2513
Bakkt Holdings
BKKT
$129M
| $26.5K | ﹤0.01% |
906
+102
| +13% | +$2.98K |
|
2514
Paysafe
PSFE
$837M
| $25.8K | ﹤0.01% |
+2,150
| New | +$25.8K |
|
2515
Hyliion Holdings
HYLN
$289M
| $25K | ﹤0.01% |
21,216
-4,198
| -17% | -$4.95K |
|
2516
Ocugen
OCGN
$322M
| $24K | ﹤0.01% |
60,090
+40,090
| +200% | +$16K |
|
|
TELL
2517
DELISTED
Tellurian Inc.
TELL
| $22.2K | ﹤0.01% |
19,096
-886
| -4% | -$1.03K |
|
|
LEV
2518
DELISTED
The Lion Electric Company
LEV
| $22K | ﹤0.01% |
+11,530
| New | +$22K |
|
2519
American Well
AMWL
$112M
| $20.6K | ﹤0.01% |
+880
| New | +$20.6K |
|
|
TRVN
2520
DELISTED
Trevena, Inc.
TRVN
| $19.9K | ﹤0.01% |
1,320
-3
| -0.2% | -$45 |
|
2521
Heron Therapeutics
HRTX
$199M
| $18.2K | ﹤0.01% |
17,712
-6,198
| -26% | -$6.38K |
|
|
AMRN
2522
Amarin Corp
AMRN
$317M
| $17.2K | ﹤0.01% |
936
+309
| +49% | +$5.68K |
|
2523
AEye
LIDR
$115M
| $17.2K | ﹤0.01% |
2,725
-67
| -2% | -$422 |
|
|
ADAP
2524
Adaptimmune Therapeutics
ADAP
$11.3M
| $17.1K | ﹤0.01% |
21,924
| – | – |
|
|
HYPD
2525
Hyperion DeFi, Inc. Common Stock
HYPD
$36.9M
| $16.6K | ﹤0.01% |
+125
| New | +$16.6K |
|